DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study

Conclusion: DV may be a useful biomarker for early prediction of therapeutic outcome in intermediate HCC. Published on 2018-04-20 13:58:11
Source: Journal of the Belgian Society of Radiology - Category: Radiology Source Type: research